Adding Blinatumomab to the CALGB 10403 Regimen in B-Cell Precursor ALL in MRD-Negative Remission | OncLive
Adding Blinatumomab to the CALGB 10403 Regimen in B-Cell Precursor ALL in MRD-Negative Remission | OncLive
8 months ago
onclive.com
Blinatumomab in First-Line ALL - Safety, Efficacy, and Experience
Blinatumomab in First-Line ALL - Safety, Efficacy, and Experience
237 viewsAug 27, 2024
vumedi.com
Blinatumomab mode of action
1:02
Blinatumomab mode of action
741 viewsJan 27, 2023
YouTubeAsif Biotech
Early Data for Subcutaneous Blinatumomab in R/R ALL | OncLive
Early Data for Subcutaneous Blinatumomab in R/R ALL | OncLive
8 months ago
onclive.com
FDA Approves BLINCYTO® (blinatumomab) To Treat Minimal Residual Disease-Positive B-Cell Precursor Acute Lymphoblastic Leukemia In Adults And Children
FDA Approves BLINCYTO® (blinatumomab) To Treat Minimal Residual Disease-Positive B-Cell Precursor Acute Lymphoblastic Leukemia In Adults And Children
Mar 29, 2018
prnewswire.com
GIMEMA LALl2317: Sequential Chemotherapy and Blinatumomab for Adult ALL | OncLive
GIMEMA LALl2317: Sequential Chemotherapy and Blinatumomab for Adult ALL | OncLive
Jul 8, 2021
onclive.com
Adding Blinatumomab to Consolidation Therapy in Older Patients With Newly Diagnosed, BCR::ABL1–Negative B-ALL | OncLive
2:12
Adding Blinatumomab to Consolidation Therapy in Older Patients With Newly Diagnosed, BCR::ABL1–Negative B-ALL | OncLive
Jan 30, 2025
onclive.com
1:36
Bispecific T-Cell Engagers (BiTEs) as Treatment of B-Cell Lymphoma
43.8K viewsDec 2, 2016
YouTubeASCOcancer
3:04
B-ALL patient selection for treatment with blinatumomab
1.1K viewsSep 28, 2021
YouTubeVJHemOnc – Video Journal of Hematology & H…
1:49
Many adults with B-cell precursor ALL have a relapse despite having minimal residual disease–negative remission with chemotherapy, and effective therapies are lacking. Research findings are summarized in a new Quick Take video. https://nej.md/4deohvj | The New England Journal of Medicine
1.3K viewsJul 28, 2024
FacebookThe New England Journal of Medicine
2:26
Optimizing blinatumomab for B-ALL
533 viewsSep 28, 2021
YouTubeVJHemOnc – Video Journal of Hematology & H…
1:43
How is blinatumomab used to treat ALL today, and how might it be used in the future?
323 views8 months ago
YouTubeKnow ALL
12:53
How is blinatumomab used to treat ALL today, and how might it be used in the future?
187 views8 months ago
YouTubeKnow ALL
2:31
Infants with acute lymphoblastic leukemia have a poor prognosis, particularly those with a KMT2A gene rearrangement. Adding blinatumomab to standard chemotherapy might improve outcomes. New research findings are summarized in this short video. https://nej.md/3HfuHwt | The New England Journal of Medicine
2.3K viewsApr 27, 2023
FacebookThe New England Journal of Medicine
3:54
A case study from the ECOG-E1910 trial: early blinatumomab treatment in ALL
236 viewsMar 8, 2024
YouTubeVJHemOnc – Video Journal of Hematology & H…
11:58
T세포로 암세포 죽이기: Bispecific T-cell Engager (BiTE) 약물, 블리나투모맙 (Blinatumomab)의 기전 이해하기
2.2K viewsNov 26, 2020
YouTubez집사TV (ZipsaTV)
9:21
Blinatumomab demonstrates significant clinical activity in residual ALL
127 viewsFeb 2, 2015
YouTubeecancer
1:03
ECOG-E1910 study: clinical benefit of early blinatumomab incorporation in ALL
437 viewsOct 12, 2023
YouTubeVJHemOnc – Video Journal of Hematology & H…
1:47
The role of blinatumomab in ALL
707 viewsJul 29, 2016
YouTubeVJHemOnc – Video Journal of Hematology & H…
0:52
Get Blincyto Blinatumomab 38.5 mg Injection
35 views10 months ago
YouTubeMilan Medicals
3:21
Blinatumomab in B-cell ALL | Maher Salamoon, MD | #EHA2025
963 views10 months ago
YouTubeHealthTree Foundation for Leukemia
2:58
ECOG-ACRIN E1910 Study On Blinatumomab In ALL Treatment – Dr. Mark R. Litzow
2.2K views8 months ago
YouTubeMD Newsline
1:14
Leukemia Breakthrough: Blinatumomab Trial Transforms Treatment
52.7K views3 months ago
YouTubeGrit-org
30:30
Blinatumomab Handling Excellence - December 11, 2025
205 views5 months ago
YouTubeInternational Academy for Clinical Hematology I…
1:46
In adults with Philadelphia chromosome–positive ALL, the use of ABL-specific TK inhibitors, with or without systemic chemotherapy, allows most patients to have a complete hematologic response; a sustained decrease in minimal residual disease is associated with an increased chance of cure. New research findings are summarized in a short video. https://nej.md/3dx0Zmw | The New England Journal of Medicine
16.6K viewsOct 22, 2020
FacebookThe New England Journal of Medicine
4:51
Blinatumomab Vs. Chemotherapy As Post-Reinduction Therapy in HR/IR First Relapse of B-ALL
156 viewsDec 10, 2019
YouTubeOncoletter
4:36
Promising results for blinatumomab in younger relapsed B-ALL
1.8K viewsDec 10, 2019
YouTubeVJHemOnc – Video Journal of Hematology & H…
8:31
Overview of blinatumomab for pediatric B-ALL
1.1K viewsJan 20, 2025
YouTubeALL Hub
2:26
Toxicity outcomes and healthcare utilization related to outpatient blinatumomab for ALL
44 views5 months ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
2:15
Blinatumomab for consolidation and maintenance in ALL
476 viewsJun 27, 2021
YouTubeVJHemOnc – Video Journal of Hematology & H…
See more